CIK 0001404644
- Non-accelerated filer
- Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 980542593
- Phone
- +1 877-237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-18 | BAKER BROS. ADVISORS LP Director | Grant or award · Prefunded Warrants | +78,325 | 78,325 | ||
| 2023-12-18 | BAKER BROS. ADVISORS LP Director | Grant or award · Prefunded Warrants | +973,290 | 973,290 | ||
| 2023-12-18 | BAKER BROS. ADVISORS LP Director | Grant or award · Prefunded Warrants | +28,782 | 107,107 | ||
| 2023-12-18 | BAKER BROS. ADVISORS LP Director | Grant or award · Prefunded Warrants | +310,130 | 1,283,420 | ||
| 2023-12-18 | BAKER BROS. ADVISORS LP Director | Grant or award · Prefunded Warrants | +20,562 | 127,669 | ||
| 2023-12-18 | BAKER BROS. ADVISORS LP Director | Grant or award · Prefunded Warrants | +221,557 | 1,504,977 | ||
| 2023-12-18 | BAKER BROS. ADVISORS LP Director | Grant or award · Prefunded Warrants | +93,480 | 221,149 | ||
| 2023-12-18 | BAKER BROS. ADVISORS LP Director | Grant or award · Prefunded Warrants | +1,151,124 | 2,656,101 | ||
| 2023-10-05 | BAKER BROS. ADVISORS LP Director | Option exercise | +57,049 | 155,874 | ||
| 2023-10-05 | BAKER BROS. ADVISORS LP Director | Option exercise | +535,601 | 1,658,190 | ||
| 2023-10-05 | BAKER BROS. ADVISORS LP Director | Option exercise · Pre-funded Warrants | −57,049 | 182,775 | ||
| 2023-10-05 | BAKER BROS. ADVISORS LP Director | Option exercise · Pre-funded Warrants | −535,601 | 1,521,176 | ||
| 2023-08-17 | BAKER BROS. ADVISORS LP Director | Purchase | +7,676 | $0.69 | $5K | 489,092 |
| 2023-08-17 | BAKER BROS. ADVISORS LP Director | Purchase | +93,091 | $0.69 | $64K | 5,551,815 |
| 2023-08-17 | BAKER BROS. ADVISORS LP Director | Purchase | +5,041 | $0.69 | $3K | 494,133 |
| 2023-08-17 | BAKER BROS. ADVISORS LP Director | Purchase | +61,134 | $0.69 | $42K | 5,612,949 |
| 2023-08-16 | BAKER BROS. ADVISORS LP Director | Purchase | +17,124 | $0.68 | $12K | 481,050 |
| 2023-08-16 | BAKER BROS. ADVISORS LP Director | Purchase | +207,676 | $0.68 | $141K | 5,454,290 |
| 2023-08-16 | BAKER BROS. ADVISORS LP Director | Purchase | +366 | $0.68 | $250 | 481,416 |
| 2023-08-16 | BAKER BROS. ADVISORS LP Director | Purchase | +4,434 | $0.68 | $3K | 5,458,724 |
Page 1 of 8 · 145 trades